Blog Archives

Motion Sensor Dyskinesia Assessment During Activities of Daily Living

C. Pulliam, M. Burack, J. Giuffrida, T. Mera 66th Annual Meeting Of The American Academy Of Neurology, Philadelphia, PA, 2014

Tagged with: , , , , ,

Wearable sensors for quantifying deep brain stimulation washout effects on gait in Parkinson’s disease

E. Brokaw, T. Mera, D. Riley, B. Walter, A. Espay, F. J. Revilla, J. Giuffrida, D. Heldman 66th  Annual Meeting of the American Academy of Neurology, Philadelphia, PA, 2014

Tagged with: , , , , , ,

PRESS RELEASE: $1.5M NIH Funding To Expand Parkinson’s Telemedicine To Mobile Apps

VIEW PRESS RELEASE 15 APR 2014: Valley View, OH – Great Lakes NeuroTechnologies (GLNT) announced today they will be using a $1.5M award from NIH to expand their Parkinson’s monitoring technology to mobile applications. Repositioning GLNT’s Kinesia™ product line with

Tagged with: , , , , , , , , , , , , , ,

PRESS RELEASE: Great Lakes NeuroTechnologies Continues Intellectual Property Growth As New Patent Claims Focus On Parkinson’s Device Accuracy And Sensitivity

VIEW PRESS RELEASE 05 MAR 2014: Valley View, OH – Great Lakes NeuroTechnologies announced today they have received a new allowance of claims from the U.S. Patent Office, the company’s fourth in the past eight months focused on technology for

Tagged with: , , , , , , , , , , , , , , , , , ,

Clinician Versus Machine: Reliability and Responsiveness of Motor Endpoints in Parkinson’s Disease

D. Heldman, A. Espay, P. Lewitt, and J. Giuffrida Parkinsonism Relat Disord. 2014;20(6):590–5.

Tagged with: , , , , , , , ,

PRESS RELEASE: Great Lakes NeuroTechnologies Launches Study to Automatically Classify Abnormal Muscle Tone in Movement Disorders

VIEW PRESS RELEASE [PDF] 15 JAN 2014: Valley View, OH – Great Lakes NeuroTechnologies (GLNT) announced today that it is launching a study to determine the feasibility of a clinician-worn glove to objectively evaluate abnormal muscle tone, such as stiff

Tagged with: , , , , , , , , , , , , , , , , , , , ,

Another Patent Allowance for GLNT

We’ve just received another patent allowance – our fourth in the past eight months – focused on technology for Parkinson’s disease diagnostics and treatment. This latest allowed patent claims cover technology that meets a critical market need for greater sensitivity

Tagged with: , , , , ,

Objective Motion Sensor Assessment Highly Correlated with Scores of Global Levodopa-Induced Dyskinesia in Parkinson’s Disease

T. Mera, M. Burack, J. Giuffrida J Parkinsons Dis. 2013 Jan 1;3(3):399-407.

Tagged with: , , , , , ,

Tradeshow Event: Partnership in Clinical Trials

The Mirage Hotel Las Vegas, NV March 31 – April 2 2014 Conference home page We will be exhibiting at booth #1305 . We will be demonstrating out Kinesia HomeView and ProView systems. From the 2013 event: This year’s event

Tagged with: , , , , , , , , , , ,

PRESS RELEASE: GLNT Expanding Telemedicine Technology for Parkinson’s Disease

VIEW PRESS RELEASE [PDF] 05 Sept 2013: Valley View, OH – Great Lakes NeuroTechnologies (GLNT) announced today they are launching commercialization and clinical studies to expand their telemedicine technology, Kinesia HomeView™ [ http://glneurotech.com/kinesia/homeview/ ], for individuals with Parkinson’s disease by

Tagged with: , , , , , , , , , , ,